Similarly, antagonizing aberrant tRNA splicing via tRNA ligase complex inhibitors (e.g., targeting RTP801 in AD) could alleviate proteotoxic stress and inflammasome activation (89). This evidence concerns the gene DDIT4 and Alzheimer disease.